Skip to content

Shattuck Labs, Inc. STTK Cash Cash Equivalents And Short Term Investments

Cash Cash Equivalents And Short Term Investments at other companies

Avalo Therapeutics logo
Avalo TherapeuticsAVTX
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
MoonLake Immunotherapeutics logo
MoonLake ImmunotherapeuticsMLTX
Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE

Other financials

Income statement

See full
Revenue-
Operating income-$15.5M-8.0%
Net income-$14.8M-7.8%
EPS (diluted)-$0.13+51.9%

Balance sheet

See full
Cash & equivalents$90.4M+48.5%
Total debt$2.9M-9.5%
Total equity$95.8M+41.8%
Total assets$102.1M+32.3%

Cash flow

See full
Operating cash flow-$13.4M-11.6%
CapEx$63.0K
Free cash flow-$13.5M-12.1%

Valuation

See full
Market cap$564.45M+1,131%
Enterprise value$476.92M-4,119%
P/S564.5×+554×

Profitability

See full
Operating margin-5,266.4%-9,520pp
Net margin-4,987.4%-8,966pp
FCF margin-4,140.8%-7,144pp

Returns & leverage

See full
Return on equity-61%-8.0pp
Debt / equity0.0×
Current ratio22.1×+13.0×

Where this comes from

Reported directly by Shattuck Labs, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsAndShortTermInvestments.

The official record: Shattuck Labs, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Shattuck Labs, Inc.'s cash cash equivalents and short term investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Shattuck Labs, Inc.'s cash cash equivalents and short term investments?
Shattuck Labs, Inc. (STTK) reported cash cash equivalents and short term investments of $90.4M in Q1 2026.
How has Shattuck Labs, Inc.'s cash cash equivalents and short term investments changed year-over-year?
Shattuck Labs, Inc.'s cash cash equivalents and short term investments increased by 48.4% year-over-year, from $60.9M to $90.4M.
What is the long-term trend for Shattuck Labs, Inc.'s cash cash equivalents and short term investments?
Over 5 years (2020 to 2025), Shattuck Labs, Inc.'s cash cash equivalents and short term investments has grown at a -25.3% compound annual growth rate (CAGR), from $335.4M to $78.1M.